Detalhe da pesquisa
1.
Foot-and-Mouth Disease Virus Induces Porcine Gasdermin E-Mediated Pyroptosis through the Protease Activity of 3Cpro.
J Virol
; 97(7): e0068623, 2023 07 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-37367489
2.
Identification of a conserved neutralizing epitope in Seneca Valley virus VP2 protein: new insight for epitope vaccine designment.
Virol J
; 19(1): 65, 2022 04 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-35410270
3.
Pharmacological Signatures of the Exenatide Nanoparticles Complex Against Myocardial Ischemia Reperfusion Injury.
Kidney Blood Press Res
; 43(4): 1273-1284, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-30078011
4.
Epidemiological and genetic characteristics of foot-and-mouth disease virus in China from 2010 to 2022.
Virology
; 589: 109940, 2024 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37984153
5.
Recombinant bacteriophage T4 displaying key epitopes of the foot-and-mouth disease virus as a novel nanoparticle vaccine.
Int J Biol Macromol
; 258(Pt 1): 128837, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-38128800
6.
Understanding cellulose pyrolysis via ab initio deep learning potential field.
Bioresour Technol
; 399: 130590, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38490462
7.
Synthesis and Functionalization of Graphene Materials for Biomedical Applications: Recent Advances, Challenges, and Perspectives.
Adv Sci (Weinh)
; 10(9): e2205292, 2023 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36658693
8.
A ferritin nanoparticle vaccine for foot-and-mouth disease virus elicited partial protection in mice.
Vaccine
; 38(35): 5647-5652, 2020 07 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-32624251
9.
Seneca Valley Virus 3C Protease Inhibits Stress Granule Formation by Disrupting eIF4GI-G3BP1 Interaction.
Front Immunol
; 11: 577838, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-33133097
10.
Comparison of immune responses to different foot-and-mouth disease genetically engineered vaccines in guinea pigs.
J Virol Methods
; 147(1): 143-50, 2008 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-17963851
11.
Porcine interferon-gamma protects swine from foot-and-mouth disease virus (FMDV).
Vet Immunol Immunopathol
; 122(3-4): 309-11, 2008 Apr 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-17996949
12.
Immunogenicity of a recombinant Sendai virus expressing the capsid precursor polypeptide of foot-and-mouth disease virus.
Res Vet Sci
; 104: 181-7, 2016 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-26850558
13.
Induction of systemic IFITM3 expression does not effectively control foot-and-mouth disease viral infection in transgenic pigs.
Vet Microbiol
; 191: 20-6, 2016 Aug 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-27374903
14.
Apigenin restricts FMDV infection and inhibits viral IRES driven translational activity.
Viruses
; 7(4): 1613-26, 2015 Mar 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-25835532
15.
Swine interferon-induced transmembrane protein, sIFITM3, inhibits foot-and-mouth disease virus infection in vitro and in vivo.
Antiviral Res
; 109: 22-9, 2014 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-24973762
16.
[Surgical treatment for hemophilic pseudotumor in maxillofacial region].
Zhonghua Kou Qiang Yi Xue Za Zhi
; 48(1): 12-4, 2013 Jan.
Artigo
em Zh
| MEDLINE | ID: mdl-23534514
17.
Radioactive seed implantation combined with prosthesis denture in treatment of oral and maxillofacial malignancy.
Cell Biochem Biophys
; 67(3): 1529-32, 2013.
Artigo
em Inglês
| MEDLINE | ID: mdl-23709313
18.
Induction of protective immunity in swine by immunization with live attenuated recombinant pseudorabies virus expressing the capsid precursor encoding regions of foot-and-mouth disease virus.
Vaccine
; 26(22): 2714-22, 2008 May 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-18436351
19.
Construction and immune response characterization of a recombinant pseudorabies virus co-expressing capsid precursor protein (P1) and a multiepitope peptide of foot-and-mouth disease virus in swine.
Virus Genes
; 36(2): 393-400, 2008 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-18246420
20.
A recombinant pseudorabies virus co-expressing capsid proteins precursor P1-2A of FMDV and VP2 protein of porcine parvovirus: a trivalent vaccine candidate.
Biotechnol Lett
; 29(11): 1677-83, 2007 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-17628752